Drug
Clear Mint, Gel Toothpaste
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Wound Infection | 139 | 254.6 | 292.6 | signal |
| 2 | Helicobacter Infection | 112 | 218.3 | 243.8 | signal |
| 3 | Hypercholesterolaemia | 93 | 192.9 | 211.2 | signal |
| 4 | Pemphigus | 119 | 189.9 | 213.6 | signal |
| 5 | Folliculitis | 95 | 182.4 | 200.1 | signal |
| 6 | Joint Dislocation | 96 | 180.8 | 198.6 | signal |
| 7 | Autoimmune Disorder | 79 | 163.5 | 176.5 | signal |
| 8 | Laryngitis | 86 | 156.9 | 170.6 | signal |
| 9 | Foot Deformity | 82 | 146.3 | 158.4 | signal |
| 10 | Red Blood Cell Sedimentation Rate Increased | 81 | 144.6 | 156.4 | signal |
| 11 | Pericarditis | 121 | 143.7 | 162.0 | signal |
| 12 | Joint Range Of Motion Decreased | 96 | 142.2 | 156.1 | signal |
| 13 | Hand Deformity | 88 | 133.1 | 144.9 | signal |
| 14 | Prescribed Underdose | 134 | 132.9 | 151.9 | signal |
| 15 | Sciatica | 98 | 122.2 | 134.4 | signal |
| 16 | Prescribed Overdose | 96 | 98.0 | 107.6 | signal |
| 17 | Hip Arthroplasty | 75 | 97.5 | 104.8 | signal |
| 18 | Wound | 135 | 95.9 | 109.6 | signal |
| 19 | Irritable Bowel Syndrome | 102 | 94.3 | 104.1 | signal |
| 20 | Synovitis | 86 | 94.1 | 102.2 | signal |
| 21 | Fibromyalgia | 115 | 93.5 | 104.7 | signal |
| 22 | Pulmonary Fibrosis | 89 | 91.9 | 100.2 | signal |
| 23 | Lower Limb Fracture | 88 | 91.0 | 99.1 | signal |
| 24 | Hepatic Cirrhosis | 85 | 89.8 | 97.5 | signal |
| 25 | Type 2 Diabetes Mellitus | 149 | 87.1 | 101.1 | signal |
| 26 | Liver Function Test Increased | 88 | 81.4 | 88.6 | signal |
| 27 | Liver Injury | 98 | 80.0 | 87.9 | signal |
| 28 | Glossodynia | 90 | 79.4 | 86.7 | signal |
| 29 | Joint Stiffness | 97 | 72.9 | 80.1 | signal |
| 30 | Disability | 67 | 66.8 | 71.2 | signal |
| 31 | C-reactive Protein Increased | 120 | 65.1 | 73.2 | signal |
| 32 | Osteoarthritis | 135 | 62.7 | 71.6 | signal |
| 33 | Knee Arthroplasty | 65 | 61.5 | 65.4 | signal |
| 34 | Ear Infection | 78 | 57.9 | 62.4 | signal |
| 35 | Impaired Healing | 95 | 57.0 | 62.5 | signal |
| 36 | Upper Respiratory Tract Infection | 133 | 56.8 | 64.7 | signal |
| 37 | Gait Inability | 94 | 56.0 | 61.3 | signal |
| 38 | Osteoporosis | 113 | 54.1 | 60.4 | signal |
| 39 | Systemic Lupus Erythematosus | 96 | 53.5 | 58.7 | signal |
| 40 | Delirium | 89 | 50.7 | 55.2 | signal |
| 41 | Psoriatic Arthropathy | 102 | 50.0 | 55.1 | signal |
| 42 | Cytokine Release Syndrome | 47 | 48.6 | 50.8 | signal |
| 43 | Drug-induced Liver Injury | 75 | 47.9 | 51.4 | signal |
| 44 | Road Traffic Accident | 95 | 44.7 | 49.0 | signal |
| 45 | Wheezing | 134 | 44.6 | 50.9 | signal |
| 46 | Oedema | 116 | 42.2 | 47.2 | signal |
| 47 | Sleep Disorder Due To A General Medical Condition | 34 | 41.4 | 42.7 | signal |
| 48 | Blood Cholesterol Increased | 97 | 41.0 | 45.0 | signal |
| 49 | Loss Of Personal Independence In Daily Activities | 79 | 32.7 | 35.2 | signal |
| 50 | Blood Iron Decreased | 19 | 31.7 | 32.3 | signal |
| 51 | Infusion Related Reaction | 106 | 31.6 | 35.0 | signal |
| 52 | Mobility Decreased | 113 | 31.1 | 34.6 | signal |
| 53 | Bursitis | 19 | 31.0 | 31.5 | signal |
| 54 | Discomfort | 92 | 29.9 | 32.6 | signal |
| 55 | Arthropathy | 83 | 29.3 | 31.7 | signal |
| 56 | Stomatitis | 89 | 28.9 | 31.4 | signal |
| 57 | Hepatic Enzyme Increased | 99 | 28.7 | 31.5 | signal |
| 58 | Musculoskeletal Stiffness | 125 | 28.1 | 31.6 | signal |
| 59 | Blister | 79 | 27.7 | 29.9 | signal |
| 60 | Breast Cancer Stage I | 13 | 27.2 | 27.6 | signal |
| 61 | Injury | 97 | 27.0 | 29.6 | signal |
| 62 | Amnesia | 82 | 24.7 | 26.7 | signal |
| 63 | Coeliac Disease | 11 | 22.0 | 22.3 | signal |
| 64 | Respiratory Tract Infection | 29 | 22.0 | 22.6 | signal |
| 65 | Sinusitis | 110 | 21.1 | 23.4 | signal |
| 66 | Oedema Peripheral | 126 | 20.3 | 22.8 | signal |
| 67 | Bronchitis | 76 | 20.1 | 21.6 | signal |
| 68 | Arthritis | 80 | 20.0 | 21.5 | signal |
| 69 | Visual Impairment | 124 | 19.8 | 22.3 | signal |
| 70 | Ear Pain | 19 | 19.2 | 19.5 | signal |
| 71 | Swelling | 91 | 19.2 | 20.9 | signal |
| 72 | General Physical Health Deterioration | 111 | 19.0 | 21.1 | signal |
| 73 | Tachycardia | 85 | 18.8 | 20.4 | signal |
| 74 | Peripheral Swelling | 146 | 18.7 | 21.5 | signal |
| 75 | Joint Swelling | 114 | 18.6 | 20.7 | signal |
| 76 | Contusion | 90 | 18.4 | 20.0 | signal |
| 77 | Sleep Disorder | 63 | 17.7 | 18.8 | signal |
| 78 | Urticaria | 146 | 17.3 | 19.8 | signal |
| 79 | Muscular Weakness | 99 | 17.1 | 18.8 | signal |
| 80 | Rheumatoid Arthritis | 96 | 16.7 | 18.3 | signal |
| 81 | Nasopharyngitis | 155 | 16.5 | 19.1 | signal |
| 82 | Back Injury | 9 | 16.3 | 16.5 | signal |
| 83 | Obesity | 13 | 16.0 | 16.2 | signal |
| 84 | Immunodeficiency | 12 | 16.0 | 16.2 | signal |
| 85 | Dyspepsia | 79 | 15.8 | 17.0 | signal |
| 86 | Contraindicated Product Administered | 24 | 15.6 | 16.0 | signal |
| 87 | Hypoaesthesia | 115 | 15.1 | 16.8 | signal |
| 88 | Asthma | 84 | 14.7 | 15.9 | signal |
| 89 | Memory Impairment | 102 | 14.6 | 16.0 | signal |
| 90 | Weight Increased | 162 | 14.3 | 16.7 | signal |
| 91 | Dental Caries | 8 | 14.2 | 14.3 | signal |
| 92 | Abdominal Discomfort | 121 | 14.2 | 15.9 | signal |
| 93 | Oral Candidiasis | 9 | 13.6 | 13.7 | signal |
| 94 | Infection | 99 | 13.5 | 14.8 | signal |
| 95 | Psoriasis | 88 | 13.2 | 14.3 | signal |
| 96 | Intentional Product Use Issue | 57 | 12.7 | 13.4 | signal |
| 97 | Spinal Disorder | 6 | 12.4 | 12.5 | signal |
| 98 | Throat Tightness | 17 | 12.4 | 12.6 | signal |
| 99 | Confusional State | 97 | 11.8 | 12.9 | signal |
| 100 | Incorrect Route Of Product Administration | 10 | 11.7 | 11.8 | signal |
| 101 | Muscle Spasticity | 7 | 11.1 | 11.2 | signal |
| 102 | Hypersensitivity | 100 | 10.6 | 11.6 | signal |
| 103 | Alopecia | 105 | 10.5 | 11.5 | signal |
| 104 | Haemoglobin Decreased | 53 | 10.1 | 10.6 | signal |
| 105 | Viral Infection | 17 | 10.1 | 10.2 | signal |
| 106 | Dyspnoea Exertional | 19 | 10.0 | 10.1 | signal |
| 107 | Gait Disturbance | 96 | 9.8 | 10.7 | signal |
| 108 | Taste Disorder | 10 | 9.8 | 9.9 | signal |
| 109 | Night Sweats | 16 | 9.8 | 9.9 | signal |
| 110 | Full Blood Count Abnormal | 5 | 9.3 | 9.4 | signal |
| 111 | Epilepsy | 14 | 9.0 | 9.1 | signal |
| 112 | Tooth Fracture | 5 | 8.9 | 9.0 | signal |
| 113 | Sneezing | 10 | 8.8 | 8.9 | signal |
| 114 | Product Taste Abnormal | 6 | 8.8 | 8.8 | signal |
| 115 | Dysphonia | 26 | 8.7 | 8.9 | signal |
| 116 | Pain In Extremity | 129 | 8.6 | 9.6 | signal |
| 117 | Back Disorder | 7 | 8.4 | 8.5 | signal |
| 118 | Lower Respiratory Tract Infection | 19 | 8.2 | 8.4 | signal |
| 119 | Economic Problem | 6 | 7.7 | 7.7 | signal |
| 120 | Basal Cell Carcinoma | 6 | 7.6 | 7.6 | signal |
| 121 | Therapeutic Product Effect Decreased | 17 | 7.5 | 7.6 | signal |
| 122 | Oral Discomfort | 5 | 7.1 | 7.1 | signal |
| 123 | Ill-defined Disorder | 20 | 6.5 | 6.6 | signal |
| 124 | Adverse Event | 30 | 6.4 | 6.6 | signal |
| 125 | Inflammatory Bowel Disease | 3 | 6.0 | 6.0 | signal |
| 126 | Pregnancy | 6 | 5.8 | 5.9 | signal |
| 127 | Maternal Exposure During Pregnancy | 26 | 5.8 | 5.9 | signal |
| 128 | Product Odour Abnormal | 3 | 5.7 | 5.7 | signal |
| 129 | Tooth Loss | 5 | 4.7 | 4.7 | signal |
| 130 | Incorrect Product Administration Duration | 4 | 3.9 | 3.9 | signal |
| 131 | Drug Exposure During Pregnancy | 4 | 2.3 | 2.3 | no signal |